NTLA — INTELLIA THERAPEUTICS INC

Ownership history in Advisory Services Network, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in INTELLIA THERAPEUTICS INC (NTLA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,889 +312 +19.8% 0.00% $33K $17.27
2023 Q4 ADDED 1,577 +316 +25.1% 0.00% $48K $30.49
2023 Q1 REDUCED 1,261 -195 -13.4% 0.00% $47K $37.27
2022 Q4 ADDED 1,456 +1,256 +628.0% 0.00% $51K $34.89
2021 Q2 REDUCED 200 -100 -33.3% 0.00% $32K $161.91
2020 Q4 INITIATED 300 — — 0.00% $16K $54.40
% of Fund (quarterly)    NTLA price (monthly, adj. close)

Other funds also holding NTLA

As of 2025 Q4 — sorted by position size

REGENERON PHARMACEUTICALS, INC. 98.49% Discovery Value Fund 3Y 7Y 2.35% Birchview Capital, LP 3Y 7Y 1.66% ARK Investment Management LLC 3Y 7Y 0.85% Orchard Capital Management, LLC 3Y 0.64% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 0.45% HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 3Y 0.32% Amova Asset Management Americas, Inc. 3Y 7Y 0.23% Elmwood Wealth Management, Inc. 3Y 7Y 0.22% Headlands Technologies LLC 3Y 0.18%
← Back to Advisory Services Network, LLC Holdings